Allied Chemical Plaskon
Product Description
Allied Chemical Plaskon was a line of phenolic molding compounds and thermosetting plastic materials manufactured under the Plaskon brand name by Allied Chemical Corporation. Plaskon products were among the early commercial synthetic resins developed for industrial applications in the United States, positioned within a broader category of phenolic compounds that became widely used in manufacturing, electrical insulation, and industrial component fabrication throughout much of the twentieth century.
Allied Chemical Corporation, a major American chemical conglomerate, marketed Plaskon materials to industrial manufacturers and fabricators who used thermosetting resins to produce molded parts, laminates, and composite components. Phenolic molding compounds of this era were valued for their dimensional stability, heat resistance, and electrical insulating properties, making them attractive for applications in electrical housings, automotive components, industrial machinery parts, and consumer goods manufacturing.
The Plaskon brand encompassed multiple formulations, including urea-formaldehyde and phenol-formaldehyde based compounds, as well as specialty resins designed for particular performance characteristics. These materials were supplied in powder, granule, or preform configurations and processed through compression molding, transfer molding, and injection molding operations at industrial facilities across the country.
Asbestos Content
Litigation records document that certain Plaskon phenolic molding compound formulations contained asbestos as a filler or reinforcing material. Asbestos was incorporated into thermosetting resin compounds during this period for several functional reasons: it improved the dimensional stability of molded parts under heat and mechanical stress, enhanced resistance to thermal degradation, and served as a reinforcing filler that reduced material costs while modifying the physical properties of the finished product.
Phenolic compounds in general were among the industrial material categories identified in asbestos-related litigation as having incorporated chrysotile and, in some formulations, amphibole asbestos varieties as functional additives. Plaintiffs alleged that Allied Chemical’s Plaskon products, in at least some product lines and production periods, contained measurable concentrations of asbestos fibers integrated throughout the resin matrix.
The specific asbestos content of any given Plaskon formulation would have varied depending on the intended application, performance specifications, and production period. Because asbestos-containing phenolic molding compounds release fibers during both processing and finishing operations, the presence of asbestos in the base resin material had direct implications for worker exposure throughout the manufacturing chain—from the compounding of the raw material to the machining and finishing of molded end products.
It should be noted that documentation of specific asbestos percentages by formulation in publicly available records is limited, and the framing of asbestos content in Plaskon products derives substantially from litigation records and plaintiff allegations rather than independently published material safety data from the period of manufacture.
How Workers Were Exposed
Industrial workers who handled, processed, or worked in proximity to Allied Chemical Plaskon phenolic molding compounds represent the primary population identified in litigation as having faced potential asbestos exposure. The exposure pathways associated with thermosetting resin compounds like Plaskon were multiple and varied by job task and facility type.
Compounding and raw material handling presented the earliest point of exposure in the manufacturing chain. Workers who received, weighed, blended, and prepared phenolic molding compound powders or granules could generate airborne dust containing asbestos fibers. Dry phenolic molding compound materials in powder form are particularly prone to dust generation during transfer, weighing, and loading operations.
Molding press operations exposed workers to potential fiber release during the loading of molds and, more significantly, during the venting of molds during the cure cycle. The heat and pressure involved in compression and transfer molding could mobilize fibers at the mold interface and in flash or overflow material removed from parts after pressing.
Deflashing, trimming, and finishing operations are among the highest-risk tasks documented in asbestos litigation involving phenolic compounds generally. Workers who used hand tools, grinding wheels, abrasive belts, or cutting equipment to remove flash, trim edges, or machine molded parts to final dimensions generated fine dust from the cured resin matrix. Plaintiffs alleged that this dust contained respirable asbestos fibers released from the disrupted material.
Maintenance and tooling workers at facilities using Plaskon and similar phenolic compounds were also identified in litigation records as potentially exposed. Workers who maintained molding presses, cleaned equipment, repaired molds, or performed general housekeeping in molding facilities could encounter accumulated dust containing asbestos derived from resin materials processed at those locations.
Quality control and laboratory personnel who tested, sectioned, or analyzed molded parts as part of production quality programs may have experienced lower but meaningful exposure through the mechanical disruption of sample materials.
The general industrial worker population is the primary trade category identified in connection with Plaskon exposure claims, reflecting the breadth of industrial facilities—from automotive parts manufacturers to electrical component producers—that used thermosetting phenolic compounds in their production operations.
Documented Trust Fund / Legal Options
Allied Chemical Plaskon falls within the Tier 2 litigation category, meaning that legal claims related to this product have been pursued through the civil court system rather than through a dedicated asbestos bankruptcy trust fund. There is no identified Allied Chemical-specific asbestos trust fund established through bankruptcy reorganization proceedings that would govern claims arising from Plaskon product exposure.
Litigation records document that claims involving Allied Chemical Plaskon have been filed as part of broader asbestos personal injury litigation, with plaintiffs alleging that exposure to asbestos-containing Plaskon phenolic compounds contributed to the development of asbestos-related diseases including mesothelioma, lung cancer, and asbestosis.
Individuals who believe they were exposed to Allied Chemical Plaskon products and have received a diagnosis of an asbestos-related disease may have legal options including:
- Direct civil litigation against Allied Chemical’s successor entities or companies that assumed relevant liabilities through corporate transactions
- Multi-defendant asbestos litigation in which Plaskon is identified as one of multiple asbestos-containing products encountered during a plaintiff’s work history
- Exploration of secondary trust fund claims if the plaintiff’s work history also involved exposure to products covered by existing asbestos bankruptcy trusts established by other manufacturers, suppliers, or installers
Because the corporate history of Allied Chemical Corporation involves mergers, acquisitions, and restructuring—Allied Chemical eventually became part of AlliedSignal and subsequently Honeywell International—the proper legal defendants and any applicable liability arrangements in current litigation are matters that require analysis by qualified asbestos litigation counsel.
Individuals with potential Plaskon exposure claims are strongly encouraged to consult with an attorney experienced in asbestos personal injury litigation who can evaluate the specific work history, confirm the applicable defendants and legal venues, and advise on the full range of available legal remedies based on current case law and litigation records.